Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew M Scott

Showing results (241-250 of 360) with videos related to

Pageof 36
Sort By:
Asia Oceania Journal of Nuclear Medicine & Biology|July 14, 2016
In vivo imaging of cellular proliferation in renal cell carcinoma using 18F-fluorothymidine PETPeter K Wong, Sze Ting Lee, Carmel Murone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 14, 2012
Dual targeting of the epidermal growth factor receptor using the combination of cetuximab and erlotinib: preclinical evaluation and results of the phase II DUX study in chemotherapy-refractory, advanced colorectal cancerAndrew J Weickhardt, Tim J Price, Geoff Chong, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 25, 2017
The Impact of <sup>68</sup>Ga-PSMA PET/CT on Management Intent in Prostate Cancer: Results of an Australian Prospective Multicenter StudyPaul J Roach, Roslyn Francis, Louise Emmett, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 3, 2025
An External, Independent Validation of an <i>O</i>-(2-[<sup>18</sup>F]Fluoroethyl)-l-Tyrosine PET Automatic Segmentation Network on a Single-Center, Prospective Dataset of Patients with GlioblastomaNathaniel Barry, Jake Kendrick, Pejman Rowshanfarzad, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 22, 2014
Targeted chemoradiation in metastatic colorectal cancer: a phase I trial of 131I-huA33 with concurrent capecitabineRebecca A Herbertson, Niall C Tebbutt, Fook-Thean Lee, et al.
Inorganic Chemistry|September 17, 2015
Toward hypoxia-selective rhenium and technetium tricarbonyl complexesAndrea J North, David J Hayne, Christine Schieber, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 17, 2003
Antitumor efficacy of cytotoxic drugs and the monoclonal antibody 806 is enhanced by the EGF receptor inhibitor AG1478Terrance G Johns, Rodney B Luwor, Carmel Murone, et al.
Cancer Immunity|February 23, 2005
Immunological effects of chimeric anti-GD3 monoclonal antibody KM871 in patients with metastatic melanomaAndrew M Scott, Zhanqi Liu, Carmel Murone, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 28, 2019
Oncogenic mutations at the EGFR ectodomain structurally converge to remove a steric hindrance on a kinase-coupled cryptic epitopeLaura Orellana, Amy H Thorne, Rafael Lema, et al.
International Journal of Radiation Oncology, Biology, Physics|April 13, 2015
Comparison of [(11)C]choline Positron Emission Tomography With T2- and Diffusion-Weighted Magnetic Resonance Imaging for Delineating Malignant Intraprostatic LesionsJoe H Chang, Daryl Lim Joon, Ian D Davis, et al.
Pageof 36

Showing results (241-250 of 360) with videos related to

Sort By:
Pageof 36
Asia Oceania Journal of Nuclear Medicine & Biology|July 14, 2016
In vivo imaging of cellular proliferation in renal cell carcinoma using 18F-fluorothymidine PETPeter K Wong, Sze Ting Lee, Carmel Murone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 14, 2012
Dual targeting of the epidermal growth factor receptor using the combination of cetuximab and erlotinib: preclinical evaluation and results of the phase II DUX study in chemotherapy-refractory, advanced colorectal cancerAndrew J Weickhardt, Tim J Price, Geoff Chong, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 25, 2017
The Impact of <sup>68</sup>Ga-PSMA PET/CT on Management Intent in Prostate Cancer: Results of an Australian Prospective Multicenter StudyPaul J Roach, Roslyn Francis, Louise Emmett, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 3, 2025
An External, Independent Validation of an <i>O</i>-(2-[<sup>18</sup>F]Fluoroethyl)-l-Tyrosine PET Automatic Segmentation Network on a Single-Center, Prospective Dataset of Patients with GlioblastomaNathaniel Barry, Jake Kendrick, Pejman Rowshanfarzad, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 22, 2014
Targeted chemoradiation in metastatic colorectal cancer: a phase I trial of 131I-huA33 with concurrent capecitabineRebecca A Herbertson, Niall C Tebbutt, Fook-Thean Lee, et al.
Inorganic Chemistry|September 17, 2015
Toward hypoxia-selective rhenium and technetium tricarbonyl complexesAndrea J North, David J Hayne, Christine Schieber, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 17, 2003
Antitumor efficacy of cytotoxic drugs and the monoclonal antibody 806 is enhanced by the EGF receptor inhibitor AG1478Terrance G Johns, Rodney B Luwor, Carmel Murone, et al.
Cancer Immunity|February 23, 2005
Immunological effects of chimeric anti-GD3 monoclonal antibody KM871 in patients with metastatic melanomaAndrew M Scott, Zhanqi Liu, Carmel Murone, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 28, 2019
Oncogenic mutations at the EGFR ectodomain structurally converge to remove a steric hindrance on a kinase-coupled cryptic epitopeLaura Orellana, Amy H Thorne, Rafael Lema, et al.
International Journal of Radiation Oncology, Biology, Physics|April 13, 2015
Comparison of [(11)C]choline Positron Emission Tomography With T2- and Diffusion-Weighted Magnetic Resonance Imaging for Delineating Malignant Intraprostatic LesionsJoe H Chang, Daryl Lim Joon, Ian D Davis, et al.
Pageof 36